Carbonic anhydrases in meningiomas: Association of endothelial carbonic anhydrase II with aggressive tumor features: Laboratory investigation

Journal of Neurosurgery

Volumn 111, Issue 3, 2009, Pages 472-477

  Korhonen, Katariina ^a   Parkkila, Anna Kaisa ^b   Helen, Pauli ^b   Välimäki, Ritva ^b   Pastorekova, Silvia ^c   Pastorek, Jaromir ^c   Parkkila, Seppo ^d   Haapasalo, Hannu ^b  

^a ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c INSTITUTE OF VIROLOGY   (Slovakia)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Cancer; Carbonic anhydrase; Immunohistochemistry; Meningioma; Tissue microarray

Indexed keywords

CARBONATE DEHYDRATASE II; ANDROGEN RECEPTOR; CARBONATE DEHYDRATASE;

ADULT; AGED; ARTICLE; BRAIN SURGERY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; RECURRENT CANCER; TISSUE MICROARRAY; VASCULAR ENDOTHELIUM; DISEASE COURSE; ENZYMOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASES; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RECEPTORS, ANDROGEN;

EID: 70350513888     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.10.17672     Document Type: Article

References (39)

1. Beasley NJ, Wykoff CC, Watson PH, Leek R, Turley H, Gatter K, et al: Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 61:5262-5267, 2001
2. Bekku S, Mochizuki H, Yamamoto T, Ueno H, Takayama E, Tadakuma T: Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology 47:998-1001, 2000
3. Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, et al: CA IX is independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 12:6421-6431, 2006
4. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, et al: Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56:941-943, 1996
5. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, et al: Prognostic significance of a novel hypoxiaregulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19:3660-3668, 2001
6. Chiang WL, Chu SC, Yang SS, Li MC, Lai JC, Yang SF, et al: The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human nonsmall cell lung cancer. Cancer Lett 188:199-205, 2002
7. Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, et al: Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61:7992-7998, 2001
8. Haapasalo J, Nordfors K, Järvelä S, Bragge H, Rantala I, Parkkila AK, et al: Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy. Neuro Oncol 3:308-313, 2007
9. Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, et al: Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 12:473-477, 2006
10. Harkonen PL, Makela SI, Valve EM, Karhukorpi EK, Vaananen HK: Differential regulation of carbonic anhydrase II by androgen and estrogen in dorsal and lateral prostate of the rat. Endocrinology 128:3219-3227, 1991
11. Hockel M, Schlenger K, Mitze M, Schaffer U, Vaupel P: Hypoxia and Radiation Response in Human Tumors. Semin Radiat Oncol 6:3-9, 1996
12. Hussain SA, Palmer DH, Ganesan R, Hiller L, Gregory J, Murray PG, et al: Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder. Oncol Rep 11:1005-1010, 2004
13. Hynninen P, Vaskivuo L, Saarnio J, Haapasalo H, Kivelä J, Pastorekova S, et al: Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumors. Histopathology 49:594-602, 2006
14. Härkönen PL, Väänänen HK: Androgen regulation of carbonic anhydrase II, a major soluble protein in rat lateral prostate tissue. Biol Reprod 38:377-384, 1988
15. Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, et al: Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158:905-919, 2001
16. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-219, 2002
17. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
18. Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasalo H: Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 80:1-7, 2006
19. Leppilampi M, Koistinen P, Savolainen ER, Hannuksela J, Parkkila AK, Niemela O, et al: The expression of carbonic anhydrase II in hematological malignancies. Clin Cancer Res 8:2240-2245, 2002
20. Liao SY, Brewer C, Zavada J, Pastorek J, Pastorekova S, Manetta A, et al: Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 145:598-609, 1994
21. Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, et al: Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61:6394-6399, 2001
22. Marks SM, Whitewell HL, Lye RH: Recurrence of meningiomas after operation. Surg Neurol 25:436-440, 1986
23. McKiernan JM, Buttyan R, Bander NH, Stifelman MD, Katz AE, Chen MW, et al: Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res 57:2362-2365, 1997
24. Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, et al: Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61:8924-8929, 2001
25. Parkkila AK, Herva R, Parkkila S, Rajaniemi H: Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours. Histochem J 27:974-982, 1995
26. Parkkila AK, Parkkila S, Rajaniemi H: Carbonic anhydrase isoenzymes II and I are present in the zona glomerulosa cells of the human adrenal gland. Histochemistry 99:37-41, 1993
27. Parkkila S, Parkkila AK, Juvonen T, Lehto VP, Rajaniemi H: Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours. Histochem J 27:133-138, 1995
28. Parkkila S, Rajaniemi H, Parkkila AK, Kivela J, Waheed A, Pastorekova S, et al: Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci U S A 97:2220-2224, 2000
29. Pastorekova S, Zavada J: Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy. Cancer Ther 2:245-262, 2004
30. Pastorekova S, Zavada Z, Kostal M, Babusikova O, Zavada J: A novel quasi-viral agent, MaTu, is a two-component system. Virology 187:620-626, 1992
31. Proescholdt MA, Mayer C, Kubitza M, Schubert T, Liao SY, Stanbridge EJ, et al: Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol 7:465-475, 2005
32. Robertson N, Potter C, Harris AL: Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res 64:6160-6165, 2004
33. Sallinen PK, Haapasalo H, Visakorpi T, Helen PT, Rantala IS, Isola J, et al: Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA and S-phase fraction using archival paraffin-embedded samples. J Pathol 174:275-282, 1994
34. Supuran CT, Briganti F, Tilli S, Chegwidden WR, Scozzafava A: Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? Bioorg Med Chem 9:703-714, 2001
35. Swietach P, Vaughan-Jones RD, Harris AL: Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26:299-310, 2007
36. Teicher BA, Liu SD, Liu JT, Holden SA, Herman TS: A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 13:1549-1556, 1993
37. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, et al: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60:7075-7083, 2000
38. Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg SR, et al: Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res 13:68-75, 2007
39. Yoshiura K, Nakaoka T, Nishishita T, Sato K, Yamamoto A, Shimada S, et al: Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res 11:8201-8207, 2005